Clinuvel Pharmaceuticals
CUV.AX
#8542
Rank
HK$2.17 B
Marketcap
HK$43.15
Share price
-0.82%
Change (1 day)
-29.98%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2026: HK$0.25 Billion

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are HK$64.99 Million. In 2026 the company made an earning of HK$0.25 Billion a decrease over its 2025 earnings that were of HK$0.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026HK$0.25 B-2.84%
2025HK$0.26 B0.26%
2024HK$0.26 B11.35%
2023HK$0.23 B28.31%
2022HK$0.18 B22.8%
2021HK$0.15 B112.63%
2020HK$71.15 M-28.73%
2019HK$99.84 M32.79%
2018HK$75.19 M75.41%
2017HK$42.86 M-332.52%
2016-HK$18.44 Million-70.68%
2015-HK$62.89 Million53.78%
2014-HK$40.9 Million-16.1%
2013-HK$48.74 Million-37.92%
2012-HK$78.51 Million-18.19%
2011-HK$95.97 Million25.31%
2010-HK$76.59 Million-21.53%
2009-HK$97.61 Million-11.27%
2008-HK$0.12 Billion80.4%
2007-HK$60.98 Million-2.46%
2006-HK$62.52 Million-5.35%
2005-HK$66.05 Million60.55%
2004-HK$41.14 Million97.37%
2003-HK$20.85 Million50.62%
2002-HK$13.84 Million121.22%
2001-HK$6.26 Million254.48%
2000-HK$1.77 Million